- Home
- NERV vs JAKK Comparison
NERV vs JAKK Comparison
Compare NERV & JAKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NERV | JAKK |
|---|---|---|
| Founded | 2007 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.1M | 189.1M |
| IPO Year | 2014 | 1996 |
Fundamental Metrics
Financial Performance| Metric | NERV | JAKK |
|---|---|---|
| Price | $4.45 | $18.70 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $4.00 | ★ $36.67 |
| AVG Volume (30 Days) | 74.6K | ★ 100.1K |
| Earning Date | 02-24-2026 | 02-19-2026 |
| Dividend Yield | N/A | ★ 5.27% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.53 |
| Revenue | N/A | ★ $574,298,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.54 |
| P/E Ratio | ★ N/A | $35.80 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.15 | $14.87 |
| 52 Week High | $12.46 | $35.79 |
Technical Indicators
Market Signals| Indicator | NERV | JAKK |
|---|---|---|
| Relative Strength Index (RSI) | 56.26 | 59.23 |
| Support Level | $3.75 | $18.47 |
| Resistance Level | $4.65 | $19.30 |
| Average True Range (ATR) | 0.35 | 0.68 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 64.71 | 60.86 |
Price Performance
Historical ComparisonAbout NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About JAKK JAKKS Pacific Inc.
Jakks Pacific Inc is a multi-product line, multi-brand toy company that designs, produces, markets, sells and distributes toys and related kid-targeted consumer products, inclusive of kids indoor and outdoor furniture, costumes and various product lines in the sporting goods and home furnishings space. Its products offering include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others. The company's products have been divided into two segments: (i) Toys/Consumer Products and (ii) Costumes.